Showing results (1531-1540 of 2,567) with videos related to

Sort By:
Pageof 257
Drug Testing and Analysis|May 11, 2012
In vitro metabolism studies on mephedrone and analysis of forensic casesAnders Just Pedersen, Lotte Ask Reitzel, Sys Stybe Johansen, et al.
Drug Testing and Analysis|May 9, 2012
Easy-to-use IEF compatible immunoaffinity purification of Erythropoietin from urine retentatesP Reihlen, E Völker-Schänzer, B Majer, et al.
Drug Testing and Analysis|April 23, 2019
Variability in content and dissolution profiles of MDMA tablets collected in the UK between 2001 and 2018 - A potential risk to users?Lewis Couchman, Anca Frinculescu, Catarina Sobreira, et al.
Drug Testing and Analysis|September 18, 2018
Longitudinally monitoring of P-III-NP, IGF-I, and GH-2000 score increases the probability of detecting two weeks' administration of low-dose recombinant growth hormone compared to GH-2000 decision limit and GH isoform test and micro RNA markersMikael Lehtihet, Hasanuzzaman Bhuiyan, Abigayle Dalby, et al.
Drug Testing and Analysis|September 23, 2018
Pharmacokinetic study of Sudaxine in dog plasma using novel LC-MS/MS methodGhaith Altawallbeh, Laura Smith, Stephen J Lewis, et al.
Drug Testing and Analysis|October 18, 2018
Meldonium long-term excretion period and pharmacokinetics in blood and urine of healthy athlete volunteersOlivier Rabin, Vladimir Uiba, Yulia Miroshnikova, et al.
Drug Testing and Analysis|October 14, 2018
Metabolic and isotopic signature of short-term DHEA administration in women: Comparison with findings in menCorinne Buisson, Claire Frelat, Kévin Privat, et al.
Drug Testing and Analysis|August 18, 2018
Suitability evaluation of new endogenous biomarkers for the identification of nitrite-based urine adulteration in mass spectrometry methodsAndrea E Steuer, Kim Arnold, Dominique Kamber, et al.
Drug Testing and Analysis|July 4, 2017
Transcriptomic biomarkers of altered erythropoiesis to detect autologous blood transfusionOlivier Salamin, Jonathan Mignot, Tiia Kuuranne, et al.
Drug Testing and Analysis|July 6, 2017
Human urinary metabolic patterns of the designer benzodiazepines flubromazolam and pyrazolam studied by liquid chromatography-high resolution mass spectrometryMadeleine Pettersson Bergstrand, Markus R Meyer, Olof Beck, et al.
Pageof 257